<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <atom:link href="https://www.health.harvard.edu/authors/robert-goldstein-md-phd/feed/rss" rel="self" type="application/rss+xml" />
        <title><![CDATA[Harvard Health Posts by Robert Goldstein, MD, PhD Feed]]></title>
        <link><![CDATA[https://www.health.harvard.edu/authors/robert-goldstein-md-phd]]></link>
        <image>
            <url>https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg</url>
            <height>173</height>
            <width>144</width>
            <title><![CDATA[Harvard Health Posts by Robert Goldstein, MD, PhD Feed]]></title>
            <link><![CDATA[https://www.health.harvard.edu/authors/robert-goldstein-md-phd]]></link>
        </image>
        <description><![CDATA[Harvard Health Blog: You'll find posts from Harvard Medical School physicians and our editors on a variety of health news and issues.]]></description>
        <language>en-US</language>
        <pubDate>Fri, 18 Jun 2021 06:30:00 -0400</pubDate>

                    <item>
                <title><![CDATA[HIV rates rising: Could new forms of PrEP help?]]></title>
                <link>https://www.health.harvard.edu/blog/hiv-rates-rising-could-new-forms-of-prep-help-202106182501</link>
                <description><![CDATA[Last year, approximately 1.7 million new HIV infections occurred worldwide, and rates of infection are also rising in parts of the US. While a daily pill known as PrEP can help prevent HIV, two new formulations could make it easier for a broader range of at-risk people to use.]]></description>
                <author><![CDATA[Robert Goldstein, MD, PhD]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/hiv-rates-rising-could-new-forms-of-prep-help-202106182501</guid>
                <pubDate>Fri, 18 Jun 2021 06:30:00 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/robert-goldstein-md-phd/feed/rss"><![CDATA[Harvard Health Posts by Robert Goldstein, MD, PhD Feed]]></source>
                                    <category>LGBTQ+ health</category>
                                    <category>Sexual Health</category>
                                    <category>Healthy aging and longevity</category>
                                    <category>Immune and infectious diseases</category>
                            </item>
                    <item>
                <title><![CDATA[U=U: Ending stigma and empowering people living with HIV]]></title>
                <link>https://www.health.harvard.edu/blog/uu-ending-stigma-and-empowering-people-living-with-hiv-2020042219583</link>
                <description><![CDATA[People living with HIV can suppress the virus by taking medication daily. If the level of virus in a person&#8217;s blood is suppressed successfully, research shows that the virus isn&#8217;t passed on to others. U=U means &#8220;undetectable equals untransmittable.&#8221;]]></description>
                <author><![CDATA[Robert Goldstein, MD, PhD]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/uu-ending-stigma-and-empowering-people-living-with-hiv-2020042219583</guid>
                <pubDate>Wed, 22 Apr 2020 14:30:08 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/robert-goldstein-md-phd/feed/rss"><![CDATA[Harvard Health Posts by Robert Goldstein, MD, PhD Feed]]></source>
                                    <category>Men&#039;s Health</category>
                                    <category>Immune and infectious diseases</category>
                                    <category>LGBTQ+ health</category>
                                    <category>Women&#039;s Health</category>
                            </item>
                    <item>
                <title><![CDATA[PrEP prevents HIV — so why aren’t more people taking it?]]></title>
                <link>https://www.health.harvard.edu/blog/prep-prevents-hiv-so-why-arent-more-people-taking-it-2019100417942</link>
                <description><![CDATA[PrEP (pre-exposure prophylaxis) is a daily medication taken to prevent HIV infection. While multiple studies show PrEP is effective, relatively few of those who might benefit are taking it. Will a 10-year initiative to reduce rates of HIV and a new formulation of PrEP help?]]></description>
                <author><![CDATA[Robert Goldstein, MD, PhD]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/prep-prevents-hiv-so-why-arent-more-people-taking-it-2019100417942</guid>
                <pubDate>Fri, 04 Oct 2019 00:00:00 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/robert-goldstein-md-phd/feed/rss"><![CDATA[Harvard Health Posts by Robert Goldstein, MD, PhD Feed]]></source>
                                    <category>Healthy aging and longevity</category>
                                    <category>Immune and infectious diseases</category>
                                    <category>LGBTQ+ health</category>
                                    <category>Men&#039;s Health</category>
                                    <category>Women&#039;s Health</category>
                                    <category>Diseases &amp; Conditions</category>
                            </item>
            </channel>
</rss>
